Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/2068
| Subject | Predicate | Object | Context |
|---|---|---|---|
| dailymed-drugs:2068 | rdf:type | http://www4.wiwiss.fu-berli... | lld:dailymed |
| dailymed-drugs:2068 | rdf:type | dailymed-instance:drugs | lld:dailymed |
| dailymed-drugs:2068 | rdfs:label | Evamist (Spray, Metered) | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:activeIng... | dailymed-ingredient:estradi... | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:genericDr... | http://www4.wiwiss.fu-berli... | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:boxedWarn... | WARNING - ENDOMETRIAL CANCER, CARDIOVASCULAR AND OTHER RISKS: ENDOMETRIAL CANCER Adequate diagnostic measures, including endometrial sampling when indicated, should be undertaken to rule out malignancy in all cases of undiagnosed persistent or recurring abnormal vaginal bleeding [see Warnings and Precautions (5.2)]. CARDIOVASCULAR AND OTHER RISKS Estrogens with or without progestins should not be used for the prevention of cardiovascular disease or dementia [see Warnings and Precautions (5.1) and (5.3) and Clinical Studies (14.4 and 14.5)]. The Women's Health Initiative (WHI) estrogen alone substudy reported increased risks of stroke and deep vein thrombosis (DVT) in postmenopausal women (50 to 79 years of age) during 6.8 years and 7.1 years, respectively, of treatment with daily oral conjugated estrogens (CE 0.625 mg), relative to placebo [see Warnings and Precautions (5.1) and Clinical Studies (14.4)]. The estrogen plus progestin WHI substudy reported increased risk of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and DVT in postmenopausal women (50 to 79 years of age) during 5.6 years of treatment with daily oral CE 0.625 mg combined with medroxyprogesterone acetate (MPA 2.5 mg), relative to placebo [see Warnings and Precautions (5.1) and (5.2) and Clinical Studies (14.4)]. The Women's Health Initiative Memory Study (WHIMS), a substudy of the WHI, reported increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 5.2 years of treatment with daily CE 0.625 mg alone and during 4 years of treatment with daily CE 0.625 mg combined with MPA 2.5 mg, relative to placebo. It is unknown whether this finding applies to younger postmenopausal women [see Warnings and Precautions (5.3), Use in Specific Populations (8.4) and Clinical Studies (14.5)]. In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and MPA and other combinations and dosage forms of estrogens and progestins. Because of these risks, estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman. | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:activeMoi... | dailymed-ingredient:estradi... | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:inactiveI... | dailymed-ingredient:ethanol | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:inactiveI... | dailymed-ingredient:octisla... | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:possibleD... | diseasome-diseases:382 | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:possibleD... | diseasome-diseases:486 | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:possibleD... | diseasome-diseases:764 | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:possibleD... | diseasome-diseases:2347 | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:possibleD... | diseasome-diseases:2539 | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:possibleD... | diseasome-diseases:3165 | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:genericMe... | estradiol | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:fullName | Evamist (Spray, Metered) | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:represent... | http://www4.wiwiss.fu-berli... | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:routeOfAd... | http://www4.wiwiss.fu-berli... | lld:dailymed |
| dailymed-drugs:2068 | dailymed-instance:name | Evamist | lld:dailymed |
| http://www4.wiwiss.fu-berli... | dailymed-instance:producesD... | dailymed-drugs:2068 | lld:dailymed |
| diseasome-diseases:382 | diseasome-instance:possible... | dailymed-drugs:2068 | lld:diseasome |
| diseasome-diseases:486 | diseasome-instance:possible... | dailymed-drugs:2068 | lld:diseasome |
| diseasome-diseases:764 | diseasome-instance:possible... | dailymed-drugs:2068 | lld:diseasome |
| diseasome-diseases:2347 | diseasome-instance:possible... | dailymed-drugs:2068 | lld:diseasome |
| diseasome-diseases:2539 | diseasome-instance:possible... | dailymed-drugs:2068 | lld:diseasome |
| diseasome-diseases:3165 | diseasome-instance:possible... | dailymed-drugs:2068 | lld:diseasome |